Peer-reviewed veterinary case report
Blood test to check shunt closure after dog liver surgery
By Devriendt, Nausikaa et al.·Published in Veterinary journal (London, England : 1997)·2026·Small Animal Department·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: The lidocaine/monoethylglycinexylidide test is a valuable alternative to protein C activity to determine shunt closure after surgical attenuation of extrahepatic portosystemic shunts in dogs.
- Species:
- dog
Plain-English summary
A group of dogs with extrahepatic portosystemic shunts (EHPSS) underwent surgery to close the abnormal blood vessels, and researchers tested two blood tests to see which was better at confirming the closure. They found that the lidocaine/monoethylglycinexylidide (MEGX) test and another test (GX) could effectively identify dogs with ongoing shunting after surgery. The GX test was particularly accurate, showing a 100% specificity for detecting persistent shunting. This means that these tests can help veterinarians determine if the surgery was successful in closing the shunts, which is crucial for the dog's recovery.
People also search for: dog portosystemic shunt surgery · EHPSS treatment in dogs · lidocaine test for dogs · dog liver shunt closure test
Abstract
The lidocaine/monoethylglycinexylidide (MEGX) test and protein C activity have both been proposed as promising blood tests to determine closure of extrahepatic portosystemic shunts (EHPSS) in dogs. The aim of this study was to compare test performances of both blood tests preoperatively and after gradual surgical attenuation of EHPSS. Firstly, MEGX and glycinexylidide (GX) were determined 15 min after intravenous administration of 1 mg/kg lidocaine in 40 healthy dogs. The 95 % left-sided reference values of MEGX and GX were 16.8 ng/mL (90 % confidence interval (CI): 11.4-22.6) and 8.3 ng/mL (90 % CI: 2.3-14.2), respectively. Subsequently, protein C activity, MEGX and GX concentrations were determined in dogs with EHPSS before surgery, one month (short-term) and minimally three months postoperatively (long-term) at which time also trans-splenic portal scintigraphy was performed to determine EHPSS closure. A total of 41 dogs with EHPSS were included; 31 dogs had closed EHPSS and ten had persisting shunting long-term. Based on the obtained reference values, dogs with persistent shunting could not be differentiated from those with a closed EHPSS with the lidocaine/MEGX test. However, after defining optimal, disease-specific, cut-off values (39.5 ng/mL for MEGX and 29.0 ng/mL for GX), sensitivity to detect persisting shunting was 88.2 % for both MEGX and GX and specificity was 67.7 % for MEGX and 100.0 % for GX. Sensitivity and specificity of protein C activity to detect persistent shunting with a cut-off of < 70 % was 62.0 % and 100.0 %, respectively. Accuracy of GX outperformed accuracy of protein C activity and MEGX to detect persistent shunting in dogs.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41412506/